IceCure Medical Ltd
General ticker "ICCM" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $49.7M (TTM average)
IceCure Medical Ltd does not follow the US Stock Market performance with the rate: -26.7%.
Estimated limits based on current volatility of 6.8%: low 0.13$, high 0.16$
Factors to consider:
- Total employees count: 55 as of 2021
- Current price 62.0% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.40$, 1.05$]
- 2026-12-31 to 2027-12-31 estimated range: [0.37$, 0.97$]
Financial Metrics affecting the ICCM estimates:
- Positive: with PPE of -2.7 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of -0.09 > -0.60
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -0.30 <= -0.16
- Positive: Shareholder equity ratio, % of 65.17 > 64.29
Short-term ICCM quotes
Long-term ICCM plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3.23MM | $3.29MM | $3.38MM |
| Operating Expenses | $18.80MM | $18.99MM | $18.47MM |
| Operating Income | $-15.58MM | $-15.70MM | $-15.09MM |
| Non-Operating Income | $0.92MM | $0.38MM | $0.04MM |
| R&D Expense | $8.27MM | $7.10MM | $7.43MM |
| Income(Loss) | $-14.65MM | $-15.32MM | $-15.06MM |
| Net Income(Loss)* | $-14.65MM | $-15.32MM | $-15.06MM |
| Stockholders Equity | $12.16MM | $6.90MM | $9.05MM |
| Inventory | $2.27MM | $1.99MM | $2.62MM |
| Assets | $16.41MM | $12.58MM | $13.89MM |
| Operating Cash Flow | $-12.52MM | $-12.56MM | $-14.57MM |
| Capital expenditure | $0.48MM | $0.07MM | $0.04MM |
| Investing Cash Flow | $-0.71MM | $0.45MM | $-0.04MM |
| Financing Cash Flow | $0.08MM | $9.19MM | $15.83MM |
| Earnings Per Share** | $-0.32 | $-0.30 | $-0.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.